![Andrea Sáez](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Andrea Sáez is currently Chief Development Officer at AgomAb Therapeutics NV since 2023.
Formerly, Dr. Sáez was Chief Operating & Scientific Officer at Origo Biopharma SL from 2020 to 2022, Director-Research & Development at Pangaea Oncology SA from 2015 to 2018, and Manager-Scientific & Regulatory Affairs at Asphalion SL from 2012 to 2015.
Dr. Sáez earned a doctorate from Universitat Pompeu Fabra.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AGOMAB THERAPEUTICS NV | Corporate Officer/Principal | 01/01/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Origo Biopharma SL
 Origo Biopharma SL BiotechnologyHealth Technology Engages in research and development of immunotherapeutic products which are focused on treating health disorders | Director de Operaciones | 01/01/2022 |
| PANGAEA ONCOLOGY, S.A. | Director Técnico/Científico/I+D | 01/09/2018 |
Asphalion SL
 Asphalion SL Miscellaneous Commercial ServicesCommercial Services Provides scientific and regulatory affairs consulting services | Director Técnico/Científico/I+D | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Universitat Pompeu Fabra
 Universitat Pompeu Fabra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pangaea Oncology SA
 Pangaea Oncology SA Medical SpecialtiesHealth Technology Provides molecular diagnostics for cancer treatment | Health Technology |
AgomAb Therapeutics NV
 AgomAb Therapeutics NV BiotechnologyHealth Technology Develops molecular therapies for regeneration of damaged tissues | Health Technology |
Origo Biopharma SL
Origo Biopharma SL BiotechnologyHealth Technology Engages in research and development of immunotherapeutic products which are focused on treating health disorders | Health Technology |
Asphalion SL
Asphalion SL Miscellaneous Commercial ServicesCommercial Services Provides scientific and regulatory affairs consulting services | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
